No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Hospitality business PPHE Hotel Group said on Friday that its independent committee had concluded that the 22 per share indicative offer from Fattal Hotel Group would not proceed after major shareholder Euro Plaza Holdings signalled its opposition.
PPHE Hotel entered an offer period in November 2025 after founder shareholders Eli Papouchado and Boris Ivesha began exploring options, including growth capital or a partial sale of their stakes. The board then launched a strategic review and began a formal sale process under a Takeover Panel dispensation.
Fattal submitted an indicative cash proposal in May, which the board judged to represent fair value. However, an independent committee was formed and consulted shareholders representing around 83% of the register, with Euro Plaza, which owns a roughly 33% stake in PPHE, telling the committee it opposed the deal.
Fattal has since said it will not proceed without Euro Plaza's support. As a result, the committee said the proposal was not deliverable in its current form.
PPHE added that it received a separate earlystage approach from another party on 31 May, which was now being assessed.
The FTSE 250-listed firm said the strategic review has been thorough and will be concluded as soon as possible, while noting there was no certainty any offer will emerge.
As of 0810 BST, PPHE shares had shed 8.70% to 1,826p.
Reporting by Iain Gilbert at Sharecast.com
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.